This filing is purely administrative — no financial restatement or operational change. Monitor the next 10-Q for any follow-on capital raises or warrant exercises by Alyeska, which holds significant exercisable warrants (Series K-1/K-2 at $4.10/share) that could create dilution.
Price Chart
Executive Summary
Intelligent Bio Solutions Inc. filed Amendment No. 1 to its FY2026 10-K to correct non-financial disclosure items: removing duplicate executive compensation tables, adding related-party transaction details for 5% holder Alyeska Master Fund (which participated in capital raises totaling ~$5.8M), and cleaning up the exhibit index. No financial statements were amended, no restatement occurred, and the auditor (UHY LLP) remains unchanged. This is a routine administrative correction with no material impact on reported financials or operations.
Key Facts
- Amendment corrects Items 11, 13, and 15 of the Original 10-K filed August 19, 2026
- No financial statements were amended or restated
- Alyeska Master Fund (5%+ holder) participated in a $5.0M December Private Placement and an ~$831K warrant inducement transaction
- Auditor remains UHY LLP (Melville, NY) — no change
- New Section 302 certifications filed; no Section 906 certifications required
- No changes to financial data, risk factors, MD&A, or internal controls
Financial Impact
No financial restatement; related-party disclosures add ~$5.8M in capital-raising transactions with Alyeska Master Fund
Risk Factors
- No new risks identified; the amendment does not alter the company's financial position or outlook
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 10-K/A Filing (Primary) | 0001493152-26-047925 |
| Exhibit: ex31-3.htm | 0001493152-26-047925 |
| Exhibit: ex31-4.htm | 0001493152-26-047925 |
| Document: 0001493152-26-047925-index-headers.html | 0001493152-26-047925 |
| Document: 0001493152-26-047925-index.html | 0001493152-26-047925 |
| Document: 0001493152-26-047925.txt | 0001493152-26-047925 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | 10-K/A | $1.69 | awaiting T+20 | — | $1.59 (−5.64%) |
Oct 13, 2026 13d ago | 8-K | $1.45 | awaiting T+20 | — | $1.59 (+9.66%) |
Sep 24, 2026 4w ago | EFFECT | $1.71 $1.69 | ▲ +1.46% | ▲ +1.04% | $1.59 (+7.02%) |
Sep 15, 2026 5w ago | S-3 | $1.97 $1.48 | ▼ −24.87% | ▼ −28.05% | $1.59 (−19.29%) |
Sep 11, 2026 6w ago | 8-K | $2.07 $1.51 | ▼ −27.05% | ▼ −29.32% | $1.59 (−23.19%) |
Sep 9, 2026 6w ago | 8-K | $2.24 $1.59 | ▼ −29.02% | ▼ −30.96% | $1.59 (−29.02%) |
Sep 2, 2026 7w ago | 8-K | $2.30 $1.66 | ▲ +27.83% | ▲ +26.64% | $1.59 (+30.87%) |
Aug 19, 2026 9w ago | 8-K | $2.67 $2.05 | ▼ −23.22% | ▼ −21.70% | $1.59 (−40.45%) |
Aug 19, 2026 9w ago | Press Release | $2.67 $2.05 | ▲ +23.22% | ▲ +21.70% | $1.59 (+40.45%) |
Aug 17, 2026 10w ago | Press Release | $3.37 $2.05 | ▼ −39.17% | ▼ −37.19% | $1.59 (−52.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers